Focus: Blue Earth Diagnostics is a UK-based molecular imaging company founded in 2014, specializing in positron emission tomography (PET) diagnostics across oncology, neurology, and cardiovascular indications. The company operates 101 active job openings and maintains a focused portfolio of FDA-approved imaging agents.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Blue Earth Diagnostics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core revenue driver with 17-year patent exclusivity; positioned as flagship diagnostic for prostate cancer localization.
Help build intelligence for Blue Earth Diagnostics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Blue Earth Diagnostics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Next-generation PSMA-targeting agent entering market expansion phase with similar long-term patent protection.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles